| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ODTC | Odonate Therapeutics, Inc. | Director, 10%+ Owner | $7.86M | Nov 17, 2021 | ||
| RAIN | Rain Oncology Inc. | Director | $0 | Jan 26, 2024 | ||
| ITOS | iTeos Therapeutics, Inc. | Director | Jun 11, 2024 | |||
| MRTX | Mirati Therapeutics, Inc. | Director | Jan 23, 2024 | |||
| TNGX | Tango Therapeutics, Inc. | Other* | Sep 3, 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|